Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

Categories

Human Remove Human filter

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

Referrals Remove Referrals filter

Referral name

Referral status

European Commission final decision (2) Apply European Commission final decision filter Opinion provided by Committee for Medicinal Products for Human Use (1) Apply Opinion provided by Committee for Medicinal Products for Human Use filter

Referral safety status

Yes Remove Yes filter

Referral type

Article 20 procedures Remove Article 20 procedures filter Article 30 referrals Remove Article 30 referrals filter Article 107 procedures (prior to July 2012) Remove Article 107 procedures (prior to July 2012) filter Article 31 referrals (4) Apply Article 31 referrals filter Article 107i procedures (4) Apply Article 107i procedures filter

Referral reference number

Referral decision making model

PRAC-CHMP-EC (3) Apply PRAC-CHMP-EC filter

Referral authorisation model

Centrally authorised product(s) (3) Apply Centrally authorised product(s) filter

Referral PRAC recommendation

Risk minimisation measures Remove Risk minimisation measures filter Suspension (1) Apply Suspension filter

Referral procedure start date

From:

To:

Referral PRAC recommendation date

From:

To:

Date of opinion

From:

To:

Decision date

From:

To:

Medicine type

Additional monitoring (2) Apply Additional monitoring filter

Related medicine

Therapeutic area

Last updated

From:

To:

This week This month Last week Last month

First published

From:

To:

3 results

Remove all filtersRemove all filters

Categories Human Remove Human filter

Medicine Referrals Remove Referrals filter

Referral type Article 30 referrals Remove Article 30 referrals filter Article 107 procedures (prior to July 2012) Remove Article 107 procedures (prior to July 2012) filter Article 20 procedures Remove Article 20 procedures filter

Referral safety status Yes Remove Yes filter

Referral PRAC recommendation Risk minimisation measures Remove Risk minimisation measures filter

Sort by

List item

Referral: Lemtrada

alemtuzumab, associated names: Lemtrada, Article 20 procedures
Status: European Commission final decision, opinion/position date: 14/11/2019, EC decision date: 16/01/2020, Last updated: 04/02/2020
List item

Referral: Xeljanz

tofacitinib, associated names: Xeljanz, Article 20 procedures
Status: European Commission final decision, opinion/position date: 14/11/2019, EC decision date: 31/01/2020, Last updated: 06/03/2020
List item

Referral: Janus kinase inhibitors (JAKi) (updated)

tofacitinib, abrocitinib, baricitinib, upadacitinib, filgotinib, associated names: Xeljanz, Cibinqo, Olumiant, Rinvoq, Jyseleca, Article 20 procedures
Status: Opinion provided by Committee for Medicinal Products for Human Use, opinion/position date: 12/01/2023, Last updated: 27/01/2023

3 results

Referral: Lemtrada

Referral: Xeljanz

Referral: Janus kinase inhibitors (JAKi) (updated)